CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models.

MLA

Li, Dan, et al. “CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Attenuates Autoimmune Dermatoses in Murine Models.” Immunopharmacology and Immunotoxicology, vol. 46, no. 4, Aug. 2024, pp. 529–37. EBSCOhost, https://doi.org/10.1080/08923973.2024.2373223.

APA

Li, D., Shan, S., Mao, X., Zhao, Y., Chen, B., Xiong, Q., Pan, D., & Huang, S. (2024). CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models. Immunopharmacology and Immunotoxicology, 46(4), 529–537. https://doi.org/10.1080/08923973.2024.2373223

Chicago

Li, Dan, Song Shan, Xuhua Mao, Yiru Zhao, Beizhong Chen, Qiuyun Xiong, Desi Pan, and Shengjian Huang. 2024. “CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Attenuates Autoimmune Dermatoses in Murine Models.” Immunopharmacology and Immunotoxicology 46 (4): 529–37. doi:10.1080/08923973.2024.2373223.